Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Naor

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Plos One|December 2, 2015
Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 DiabetesNathalie Assayag-Asherie, Dror Sever, Marika Bogdani, et al.
Cancer Research|November 3, 2012
CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motilityTamara Girbl, Elisabeth Hinterseer, Eva Melanie Grössinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2004
RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancyShlomo Nedvetzki, Erez Gonen, Nathalie Assayag, et al.
Annals of the New York Academy of Sciences|October 4, 2007
CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout miceDavid Naor, Shlomo Nedvetzki, Marita Walmsley, et al.
The Journal of Clinical Investigation|February 7, 2009
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilizationYaron Vagima, Abraham Avigdor, Polina Goichberg, et al.
Journal of Autoimmunity|July 23, 2013
Immunological and autoimmune considerations of Autism Spectrum DisordersBenjamin Gesundheit, Joshua P Rosenzweig, David Naor, et al.
Journal of Autoimmunity|August 14, 2021
MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid AMaayan Hemed-Shaked, Mary K Cowman, Jin Ryoun Kim, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Plos One|December 2, 2015
Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 DiabetesNathalie Assayag-Asherie, Dror Sever, Marika Bogdani, et al.
Cancer Research|November 3, 2012
CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motilityTamara Girbl, Elisabeth Hinterseer, Eva Melanie Grössinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2004
RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancyShlomo Nedvetzki, Erez Gonen, Nathalie Assayag, et al.
Annals of the New York Academy of Sciences|October 4, 2007
CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout miceDavid Naor, Shlomo Nedvetzki, Marita Walmsley, et al.
The Journal of Clinical Investigation|February 7, 2009
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilizationYaron Vagima, Abraham Avigdor, Polina Goichberg, et al.
Journal of Autoimmunity|July 23, 2013
Immunological and autoimmune considerations of Autism Spectrum DisordersBenjamin Gesundheit, Joshua P Rosenzweig, David Naor, et al.
Journal of Autoimmunity|August 14, 2021
MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid AMaayan Hemed-Shaked, Mary K Cowman, Jin Ryoun Kim, et al.
Pageof 3